| Bioactivity | eIF4E-IN-1 is a potent inhibitor of eIF4E. eIF4E-IN-1 inhibits immunosuppression components such as immune checkpoint proteins PD-1, PD-L1, LAG3, TIM3, and/or IDO, in order to inhibit or release immune suppression in certain diseases, such as cancer and infectious disease (extracted from patent WO2021003194A1, compound Y)[1]. |
| Target | eIF4E |
| Name | eIF4E-IN-1 |
| CAS | 2573979-31-2 |
| Formula | C33H28ClF3N6O4S |
| Molar Mass | 697.13 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kevin R, et al. Eif4e inhibitors for use as immune checkpoint modulators and related methods. Patent WO2021003194A1. |
eIF4E-IN-1
CAS: 2573979-31-2 F: C33H28ClF3N6O4S W: 697.13
eIF4E-IN-1 is a potent inhibitor of eIF4E. eIF4E-IN-1 inhibits immunosuppression components such as immune checkpoint pr
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.